Guerzoni, S. (2024) “Anti-CGRP monoclonal antibodies improve cognitive function in patients affected by chronic migraine complicated with medication overuse-headache”, Confinia Cephalalgica, 34(1). doi: 10.4081/cc.2024.15760.